PATENT CLAIM ANALYSIS

Application Number: 16009303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Claim (Index 1):
A method of treating a disease of genetic and/or viral origin or a method of treating a tumor in a patient in need thereof with a composition comprising at least one single strand anti-gene oligonucleotide complementary to the anti-sense DNA strand of a target gene, comprising 6-30 nucleotides, said oligonucleotides being characterized by a sequence comprising at least three groups of at least two consecutive guanines, said disease of genetic and/or viral origin and said tumor being caused by an overexpression and/or inhibition of a gene,\n said method comprising administering to said patient in need an effective amount of said composition; and treating said patient.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14780043', '14533371', '15882221', '15364050', '15222695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7094241575941183
- 35 USC 102 Novelty (BERT): 0.5045674963982905
- Combined Prediction Score: 0.6889384914745355
- Mean Citation Score: 236.347142
- Max Citation Score: 246.64674
- Similarity Product: 181.48097281064983

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test